The FDA announced on July 26, 2017, that Hospira Inc. is recalling Hydromorphone Hydrochloride Injection due to the presence of silicone oil particulate matter. The agency classified the recall as Class II.
How to tell if you have it
- Brand: Hospra
- Product: Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial
- NDC: 0703-0018-01
- Lot #: 560053F
- Expiration: 01AUG2017
The hazard
The recall addresses the presence of particulate matter, specifically silicone oil, in the injection vials. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Hospira Inc. has one other recall on record since June 4, 2018. On June 4, 2018, the company recalled Naloxone Injection due to a particulate matter risk involving potential particles on the syringe plunger. Other recent recalls of similar products include American Regent Papaverine HCl Injection (July 24, 2026), American Regent Tralement injection (July 24, 2026), and Sun Pharmaceutical DOXOrubin Liposome Injection (May 12, 2026).